JP Morgan Chase
VIVS

JP Morgan Chase’s VivoSim Labs VIVS Stock Holding History

JP Morgan Chase’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-417
Closed -$725K – 4305
2014
Q4 		$725K Buy
+417
New +$641K ﹤0.01% 3509

Other funds holding VIVS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return

JP Morgan Chase's VIVS Position: Q1 2026 in Review

JP Morgan Chase sold out of VivoSim Labs (VIVS) in Q1 2026, closing a stake of 3 shares — an estimated $5 sold.

JP Morgan Chase first reported a position in VIVS in Q4 2015 and held it in 41 quarters. The position peaked at $43K in Q2 2016. 24 funds tracked by Wall St. Rank hold VIVS as of Q1 2026.

  • JP Morgan Chase reported no remaining VivoSim Labs position as of Q1 2026 after selling out during the quarter.
  • JP Morgan Chase sold 3 VivoSim Labs shares in Q1 2026, an estimated $5.
  • JP Morgan Chase first reported a position in VivoSim Labs in Q4 2015 and held it in 41 quarters.
  • JP Morgan Chase's VivoSim Labs position peaked at $43K in Q2 2016.
  • 24 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.